225Ac-J591,177Lu-PSMA-I
novartis
['crpc', '225ac']
 225ac-j591 in combination with 177lu-psma-i exciting findings from #asco2023: combination of 225ac-j591 and 177lu-psma i&amp;t proves to be a feasible approach in mcrpc patients without new safety signals. alfa-radiolabeled antibody 225ac-j591 and beta-radioligand 
Leader GU @InstitutoRoffo #GU #RCC #prostate #bladder #testis #GUcsm #clinicaltrials #Immunotherapy #PrecisionMedicine #OncoAlert #OncoReporte
Views Mine